Duloxetine treatment of stress urinary incontinence in women: Effects of demographics, obesity, chronic lung disease, hypoestrogenism, diabetes mellitus, and depression on efficacy

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 133, Issue 1, 2007, Pages 105-113

  Viktrup, Lars ^a,b   Yalcin, Ilker ^a  

^a ELI LILLY AND COMPANY   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

BMI; Chronic lung disease; Demographic; Diabetes; Hypoestrogenism; Stress urinary incontinence

Indexed keywords

DULOXETINE; PLACEBO;

ADULT; AGED; ALGORITHM; ARTICLE; BODY MASS; CHRONIC LUNG DISEASE; COMORBIDITY; CONSTIPATION; CONTROLLED STUDY; DEMOGRAPHY; DEPRESSION; DIABETES MELLITUS; DIARRHEA; DIZZINESS; DRUG DOSE ESCALATION; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG WITHDRAWAL; ESTROGEN DEFICIENCY; ETHNICITY; FATIGUE; FEMALE; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; NAUSEA; OBESITY; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; REFERENCE DATABASE; SCORING SYSTEM; SOMNOLENCE; STRESS INCONTINENCE; TREATMENT OUTCOME; TREATMENT RESPONSE; XEROSTOMIA;

EID: 34250717995     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2006.05.003     Document Type: Article

References (31)

1. Abrams P., Cardozo L., Fall M., et al. The standardisation of terminology of lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Am J Obstet Gynecol 187 1 (2002) 116-126
2. Koelbl H., Mostwin J., Boiteux J.P., et al. Pathophysiology. In: Abrams P., Cardozo L., Khoury S., and Wein A. (Eds). Incontinence. 2nd ed. (2002), Health Publication Ltd., Plymouth 203-241
3. Bump R.C. Racial comparisons and contrasts in urinary incontinence and pelvic organ prolapse. Obstet Gynecol 81 3 (1993) 421-425
4. Viktrup L., Koke S., Burgio K.L., and Ouslander J.G. Stress urinary incontinence in active elderly women. Southern Med J 98 1 (2005) 79-89
5. Moller L.A., Lose G., and Jorgensen T. The prevalence and bothersomeness of lower urinary tract symptoms in women 40-60 years of age. Acta Obstet Gynecol Scand 79 4 (2000) 298-305
6. Bump R., and McClish D. Cigarette smoking and pure genuine stress incontinence of urine: a comparison of risk factors and determinants between smokers and nonsmokers. Am J Obstet Gynecol 170 2 (1994) 579-582
7. Katofiasc M.A., Nissen J., Audia J.E., and Thor K.B. Comparison of the effects of serotonin selective, norepinephrine selective, and dual serotonin and norepinephrine reuptake inhibitors on lower urinary tract function in cats. Life Sci. 71 (2002) 1227-1236
8. Thor K.B., and Katofiasc M.A. Effects of duloxetine, a combined serotonin and norepinephrine reuptake inhibitor, on central neural control of lower urinary tract function in the chloraloseanesthetized female cat. J Pharmacol Exp Ther 274 2 (1995) 1014-1024
9. Norton P.A., Zinner N.R., Yalcin I., and Bump R.C. Duloxetine versus placebo in the treatment of stress urinary incontinence. Am J Obstet Gynecol 187 1 (2002) 40-48
10. Dmochowski R.R., Miklos J.R., Norton P.A., et al. Duloxetine vs. placebo in the treatment of North American women with stress urinary incontinence. J Urol 170 4 Pt 1 (2003) 1259-1263 Erratum in: J Urol 2004;171(1):360
11. Van Kerrebroeck P., Abrams P., Lange R., et al. Duloxetine vs. placebo in the treatment of European and Canadian women with stress urinary incontinence. Eur Urol 2 Suppl (2003) 29
12. Millard R.J., Moore K., Rencken R., et al. Duloxetine vs. placebo in the treatment of stress urinary incontinence: a four-continent randomized clinical trial. BJU Int. 93 3 (2004) 311-318
13. Hurley D.J., Turner C.L., Yalcin I., Viktrup L., and Baygani S.K. Duloxetine for the treatment of stress urinary incontinence in women: an integrated analysis of safety. Eur J Obstet Gynecol Reprod Biol 125 1 (2006) 120-128
14. Bump R, Hooper C, Koke S, Yalcin I. The effect of baseline severity on the efficacy of duloxetine in the treatment of women with stress urinary incontinence (SUI). Abstract # 275 at Joint Meeting of the International Continence Society and The International UroGynecological Association 34th Annual Meeting Paris, France, 25th-27th August 2004.
15. Yalcin I., and Bump R.C. The effect of previous treatment experience and incontinence severity on the placebo response of stress urinary incontinence. Am J Obstet Gynecol 191 1 (2004) 194-197
16. Bump R.C., Mattiasson A., Bø K., et al. The standardisation of terminology of female pelvic organ prolapse and pelvic floor dysfunction. Am J Obstet Gynecol 175 (1996) 10-17
17. Perucchini D., DeLancey J.O., Ashton-Miller J.A., Galecki A., and Schaer G.N. Age effects on urethral striated muscle. I. Changes in number and diameter of striated muscle fibers in the ventral urethra. Am J Obstet Gynecol 186 3 (2002) 351-355
18. Pandit M., DeLancey J.O., Ashton-Miller J.A., Iyengar J., Blaivas M., and Perucchini D. Quantification of intramuscular nerves within the female striated urogenital sphincter muscle. Obstet Gynecol 95 (2000) 797-800
19. Burgio K.L., Matthews K.A., and Engel B.T. Prevalence, incidence and correlates of urinary incontinence in healthy, middle-aged women. J Urol 146 5 (1991) 1255-1259
20. Peacock L.M., Wiskind A.K., and Wall L.L. Clinical features of urinary incontinence and urogenital prolapse in a black inner-city population. Am J Obstet Gynecol 171 6 (1994) 1464-1471
21. Skinner D.P. Stress incontinence: a comparative racial study. Med Proc (Mediese Bydraes) 9 (1963) 189-194
22. Knobel J. Stress incontinence in the black female. S Afr Med J 49 12 (1975) 430-432
23. Coffey R.M., Andrews R.M., and Moy E. Racial, ethnic, and socioeconomic disparities in estimates of AHRQ patient safety indicators. Med Care 43 3 Suppl (2005) I48-I57
24. Mattox T.F., and Bhatia N.N. The prevalence of urinary incontinence or prolapse among white and hispanic women. Am J Obstet Gynecol 174 2 (1996) 646-648
25. Mendez M.A., Monteiro C.A., and Popkin B.M. Overweight exceeds underweight among women in most developing countries. Am J Clin Nutr 81 3 (2005) 714-721
26. Parazzini F., Colli E., Origgi G., et al. Risk factors for urinary incontinence in women. Eur Urol 37 6 (2000) 637-643
27. DuBeau C.E. Estrogen treatment for urinary incontinence: never, now, or in the future?. JAMA 293 8 (2005) 998-1001
28. Hendrix S.L., Cochrane B.B., Nygaard I.E., Handa V.L., Barnabei V.M., and Iglesia C. Effects of estrogen with and without progestin on urinary incontinence. JAMA 293 8 (2005) 935-948
29. Grady D., Brown J.S., Vittinghoff E., et al. Postmenopausal hormones and incontinence: the Heart and Estrogen/Progestin Replacement Study. Obstet Gynecol 97 (2001) 116-120
30. Diokno A.C., Brock B.M., Herzog A.R., and Bromberg J. Medical correlates of urinary incontinence in the elderly. Urology 36 2 (1990) 129-138
31. Brown E.G., Wood L., and Wood S. The medical dictionary for regulatory activities (MedRA). Drug Saf 20 (1999) 109-117